# Safety and Efficacy of SeeMore (TM) in Heart Patients

> **NCT00881075** · PHASE2 · COMPLETED · sponsor: **Eagle Vision Pharmaceutical Corp.** · enrollment: 24 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** SeeMore(TM)

## Key facts

- **NCT ID:** NCT00881075
- **Lead sponsor:** Eagle Vision Pharmaceutical Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00881075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00881075, "Safety and Efficacy of SeeMore (TM) in Heart Patients". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00881075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*